BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 3511581)

  • 1. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
    Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
    Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study.
    Novick AC; Hwei HH; Steinmuller D; Streem SB; Cunningham RJ; Steinhilber D; Goormastic M; Buszta C
    Transplantation; 1986 Aug; 42(2):154-8. PubMed ID: 3526655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
    Slakey DP; Johnson CP; Callaluce RD; Browne BJ; Zhu YR; Roza AM; Adams MB
    Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
    Matas AJ; Tellis VA; Quinn TA; Glicklich D; Soberman R; Veith FJ
    Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
    Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
    Boudreaux JP; McHugh L; Canafax DM; Ascher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
    Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients.
    Michael HJ; Francos GC; Burke JF; Besarab A; Moritz M; Gillum D; Jarrell B
    Transplantation; 1989 Nov; 48(5):805-8. PubMed ID: 2683263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclosporine and delayed graft function on posttransplantation erythropoiesis.
    Besarab A; Caro J; Jarrell B; Burke J; Francos G; Mallon E; Karsch R
    Transplantation; 1985 Dec; 40(6):624-31. PubMed ID: 3907033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.
    Canadian Multicentre Transplant Study Group
    N Engl J Med; 1986 May; 314(19):1219-25. PubMed ID: 2871486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine.
    Hall BM; Tiller DJ; Duggin GG; Horvath JS; Farnsworth A; May J; Johnson JR; Sheil AG
    Kidney Int; 1985 Aug; 28(2):178-86. PubMed ID: 3914572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols.
    Suthanthiran M; Haschemeyer RH; Riggio RR; Adubor C; Friedman GS; Cheigh JS; Wang JC; Fotino M; Stubenbord WT; Saal SD
    Transplantation; 1993 May; 55(5):1008-13. PubMed ID: 8497873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplantation; 1989 Jan; 47(1):96-102. PubMed ID: 2643236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry M; Ferguson RM
    Transplantation; 1987 Jan; 43(1):85-90. PubMed ID: 3541330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
    J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantation.
    Novick AC; Braun WE; Steinmuller D; Buszta C; Greenstreet R; Kiser W
    Transplantation; 1983 Feb; 35(2):175-9. PubMed ID: 6338636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin.
    Gruber SA; Pescovitz MD; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Fryd DS
    Transplantation; 1987 Dec; 44(6):775-8. PubMed ID: 3321586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.